Selective testing criteria for gonorrhea among young women screened for chlamydial infection: Contribution of race and geographic prevalence

Journal of Infectious Diseases

Volumn 196, Issue 5, 2007, Pages 731-737

  Manhart, Lisa E ^a,d   Marrazzo, Jeanne M ^a   Fine, David N ^b   Kerani, Roxanne P ^c   Golden, Matthew R ^a,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Center for Health Training   (United States)

^c Public Health Seattle King County   (United States)

^d Center for AIDS and STD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; AMERICAN INDIAN; ARTICLE; CHLAMYDIASIS; FEMALE; GONORRHEA; HUMAN; MAJOR CLINICAL STUDY; MASS SCREENING; NEISSERIA GONORRHOEAE; PATIENT SELECTION; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE; URETHRITIS; VAGINA DISCHARGE;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; CONTINENTAL POPULATION GROUPS; FEMALE; GEOGRAPHY; GONORRHEA; HUMANS; PREVALENCE; UNITED STATES;

EID: 34548107326     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/520517     Document Type: Article

References (33)

1. Parran T. Shadow on the land: syphilis. New York: Reynal and Hitchcock, 1937.
2. Brown ST, Wiesner PJ. Problems and approaches to the control and surveillance of sexually transmitted agents associated with pelvic inflammatory disease in the United States. Am J Obstet Gynecol 1980; 138:1096-100.
3. Katcher ML, Addiss DG, Vaughn ML. Chlamydia trachomatis screening in family planning clinics in Wisconsin. Wis Med J 1986; 85:27.
4. Addiss DG, Vaughn ML, Hillis SD, Ludka D, Amsterdam L, Davis JP. History and features of the Wisconsin Chlamydia trachomatis control program. Fam Plann Perspect 1994; 26:83-6, 89.
5. Britton TF, Delisle S, Fine D. STDs and family planning clinics: a regional program for chlamydia control that works. Am J Gynecol Health 1992; 6:80-7.
6. Marrazzo JM, Celum CL, Hillis SD, Fine D, DeLisle S, Handsfield HH. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women: implications for a national Chlamydia control strategy. Sex Transm Dis 1997; 24:131-41.
7. Marrazzo JM, Fine D, Celum CL, DeLisle S, Handsfield HH. Selective screening for chlamydial infection in women: a comparison of three sets of criteria. Fam Plann Perspect 1997; 29:158-62.
8. Miller WC, Hoffman IF, Owen-O'Dowd J, et al. Selective screening for chlamydial infection: which criteria to use? Am J Prev Med 2000; 18: 115-22.
9. US Preventive Services Task Force. Screening for gonorrhea: recommendation statement. Available at: http://www.ahrq.gov/clinic/uspstf05/ gonorrhea/gonrs.pdf. Accessed 20 March 2007.
10. Dicker LW, Mosure DJ, Steece R, Stone KM. Testing for sexually transmitted diseases in U.S. public health laboratories in 2004. Sex Transm Dis 2007; 34:41-6.
11. Miller WC, Ford CA, Morris M, et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 2004; 291:2229-36.
12. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 2005. Atlanta: US Department of Health and Human Services, 2006.
13. Dicker LW, Mosure DJ, Berman SM, Levine WC. Gonorrhea prevalence and coinfection with chlamydia in women in the United States, 2000. Sex Transm Dis 2003; 30:472-6.
14. Golden MR, Hughes JP, Cles LE, et al. Positive predictive value of GenProbe APTIMA Combo 2 testing for Neisseria gonorrhoeae in a population of women with low prevalence of N. gonorrhoeae infection. Clin Infect Dis 2004; 39:1387-90.
15. Katz AR, Effler PV, Ohye RG, Brouillet B, Lee MV, Whiticar PM. False-positive gonorrhea test results with a nucleic acid amplification test: the impact of low prevalence on positive predictive value. Clin Infect Dis 2004; 38:814-9.
16. Smith DW, Tapsall JW, Lum G. Guidelines for the use and interpretation of nucleic acid detection tests for Neisseria gonorrhoeae in Australia: a position paper on behalf of the Public Health Laboratory Network. Commun Dis Intell 2005; 29:358-65.
17. Gift TL, Lincoln T, Tuthill R, et al. A cost-effectiveness evaluation of a jail-based chlamydia screening program for men and its impact on their partners in the community. Sex Transm Dis 2006; 33:S103-10.
18. Hook EW III, Handsfield HH. Gonococcal infections in the adult. In: Holmes KK, Sparling PF, Mardh P-A, et al., eds. Sexually transmitted diseases. 3rd ed. New York: McGraw-Hill, 1999:451-66.
19. Jennings JM, Curriero FC, Celentano D, Ellen JM. Geographic identification of high gonorrhea transmission areas in Baltimore, Maryland. Am J Epidemiol 2005; 161:73-80.
20. US Centers for Disease Control and Prevention (CDC). infertility prevention project. Vol. 2006. Atlanta: CDC, 2006.
21. Adimora AA, Schoenbach VJ, Martinson FE, Donaldson KH, Fullilove RE, Aral SO. Social context of sexual relationships among rural African Americans. Sex Transm Dis 2001; 28:69-76.
22. Adimora, AA, Schoenbach VJ, Bonas DM, Martinson FE, Donaldson KH, Stancil TR. Concurrent sexual partnerships among women in the United States. Epidemiology 2002; 13:320-7.
23. Hallfors DD, Iritani BJ, Miller WC, Bauer DJ. Sexual and drug behavior patterns and HIV and STD racial disparities: the need for new directions. Am J Public Health 2007; 97:125-32.
24. Mertz KJ, Voigt RA, Hutchins K, Levine WC. Findings from STD screening of adolescents and adults entering corrections facilities: implications for STD control strategies. Sex Transm Dis 2002; 29:834-9.
25. Kahn RH, Mosure DJ, Blank S, et al. Chlamydia trachomatis and Neisseria gonorrhoeae prevalence and coinfection in adolescents entering selected US juvenile detention centers, 1997-2002. Sex Transm Dis 2005; 32:255-9.
26. Mehta SD, Bishai D, Howell MR, Rothman RE, Quinn TC, Zenilman JM. Cost-effectiveness of five strategies for gonorrhea and chlamydia control among female and male emergency department patients. Sex Transm Dis 2002; 29:83-91.
27. Aledort JE, Hook EW III, Weinstein MC, Goldie SJ. The cost effectiveness of gonorrhea screening in urban emergency departments. Sex Transm Dis 2005; 32:425-36.
28. Howard H, Chow JM, Bauer HM, et al. Gonorrhea screening strategies and guideline development for non-pregnant female patients in the California family planning clinic setting [abstract D06D]. In: Program and abstracts of the 2004 National STD Prevention Conference (Philadelphia). 2004:A77.
29. Sexually Transmitted Diseases (STD) Control Branch. California guidelines for gonorrhea screening and diagnostic testing among women in family planning and primary care settings. California Department of Health Services, 2005.
30. Diemert DJ, Libman MD, Lebel P. Confirmation by 16S rRNA PCR of the COBAS AMPLICOR CT/NG test for diagnosis of Neisseria gonorrhoeae infection in a low-prevalence population. J Clin Microbiol 2002; 40:4056-9.
31. Geraats-Peters CW, Brouwers M, Schneeberger PM, et al. Specific and sensitive detection of Neisseria gonorrhoeae in clinical specimens by real-time PCR. J Clin Microbiol 2005; 43:5653-9.
32. Airell A, Lindback E, Ataker F, Pornull KJ, Wretlind B. Verification of clinical samples, positive in AMPLICOR Neisseria gonorrhoeae polymerase chain reaction, by 16S rRNA and gyrA compared with culture. Int J STD AIDS 2005; 16:415-9.
33. Johnson RE, Newhall WJ, Papp JR, et al. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections - 2002. MMWR Recomm Rep 2002; 51:1-38; quiz CE1-4.